Clinical Trials

Find a Trial

Trial Results

10 protocol(s) meet the specified criteria
BAY94-9343OPEN TO ACCRUAL
Phase 1b Multi-indication Study of Anetumab Ravtansine (BAY 94-9343)in Patients with Mesothelin Expressing Advanced or Recurrent Malignancies
CANSTEM111POPEN TO ACCRUAL
A Phase III Study of BBI-608 plus nab-Paclitaxel with Gemcitabine in Adult Patients with Metastatic Pancreatic Adenocarcinoma.
IUCRO-0309OPEN TO ACCRUAL
IU Pancreatic Lesion Tissue/Fluid Bank
IUCRO-0454OPEN TO ACCRUAL
Molecular Phenotyping of Pancreatic Cancer Cachexia: A Bridge to Personalized Targeted Therapy
IUCRO-0495OPEN TO ACCRUAL
Creation of a Pancreatic Cancer Outcome Database with Blood Storage
IUSCC-0565OPEN TO ACCRUAL
Pilot study of respiratory-gated stereotactic body radiation therapy for boderline resectable, unresectable, or recurrent/residual adenocarcinoma of the pancreas or periampullary region.
IUSCC-0597OPEN TO ACCRUAL
A phase II trial of cabozantinib and erlotinib for patients with EGFR and c-Met co-expressing metastatic pancreatic adenocarcinoma
IUSCC-0632OPEN TO ACCRUAL
Pilot Study to Examine Correlation of Nab-Paclitaxel/Gemcitabine Pharmacokinetics with Cachexia
RTOG-0848OPEN TO ACCRUAL
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (PH II-R) and Chemoradiation (PHIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
SURG-DUKE-CEPPA-VACOPEN TO ACCRUAL
A Randomized Phase II Evaluation of Negative Pressure Wound Therapy for Reduction of Postoperative Surgical Site Infection in Patients Undergoing Colorectal and Hepatopancreatobiliary Surgery